98%
921
2 minutes
20
This article provides an overview of the current state of assessment and clinical intervention approaches for youth with juvenile legal system (JLS) involvement. The review includes () a brief overview of characteristics of youth with JLS involvement; () current screening and assessment frameworks within the JLS that identify treatment needs; () an overview of effective clinical interventions for common behavioral health concerns among youth with JLS involvement, including information about tailoring interventions to address the multiple intersecting identities (e.g., race, ethnicity, gender identity, sexual orientation) of youth within the JLS; and () an overview of implementation models and scalability of interventions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1146/annurev-clinpsy-081423-021503 | DOI Listing |
Res Child Adolesc Psychopathol
September 2025
Center for Dissemination and Implementation Science, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Cannabis use is common among US youth who become involved in the juvenile legal system (JLS), yet substance use treatment rates remain low, particularly among youth diverted away from formal JLS involvement. Diverted youth encounter multiple barriers to receiving services in the community that could be addressed via digital approaches offered by the JLS. This multiphase work details development of the TECH (Teen Empowerment through Computerized Health) app, a tailored digital adjunct to usual JLS services.
View Article and Find Full Text PDFPsychol Inj Law
September 2024
University of California, San Francisco; Department of Psychiatry and Behavioral Sciences.
Background: Adolescents involved in the juvenile legal system (JLS) have higher rates of mental health treatment needs compared to their non-justice-involved peers, and they experience disproportionate rates of trauma exposure and trauma-related psychosocial concerns. Most research comparing these adolescent groups draws data from separate studies, making it more challenging to understand meaningful differences between the two groups. Research documenting making such comparisons can guide prevention and intervention strategies for communities and their juvenile detention centers.
View Article and Find Full Text PDFSemin Respir Crit Care Med
August 2025
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California San Francisco, San Francisco, California.
Bleomycin-induced lung injury remains the most widely used and well-characterized experimental model for studying pulmonary fibrosis, particularly idiopathic pulmonary fibrosis (IPF). This review provides a comprehensive analysis of the bleomycin model's utility, phases, variability, and translational relevance. Bleomycin administration in rodents induces acute epithelial injury followed by inflammation, fibroblast activation, extracellular matrix deposition, and eventual fibrosis.
View Article and Find Full Text PDFBMJ Neurol Open
July 2025
Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
Background: In a retrospective multicentre cohort study, we explored the association between brain atrophy and multiple sclerosis (MS) disability using different MRI scanners and protocols at multiple sites.
Methods: Relapse-onset MS patients were included if they had two clinical MRIs 12 months apart and ≥2 Expanded Disability Status Scale (EDSS) scores. Percentage brain volume change (PBVC), percentage grey matter change (PGMC), fluid-attenuated inversion recovery (FLAIR) lesion volume change, whole brain volume (BV), grey matter volume (GMV), FLAIR lesion volume and T1 hypointense lesion volume were assessed by icobrain.